Sirolimus

NDC 55111-654 · Dr. Reddy's Laboratories Limited

Generic nameSirolimus

Dosage formTABLET

RouteORAL

Active ingredient(s)SIROLIMUS

Strength2 mg/1

Pharmacologic classDecreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]

Marketing categoryANDA

Packages

55111-654-01 — 100 TABLET in 1 BOTTLE (55111-654-01)

55111-654-30 — 30 TABLET in 1 BOTTLE (55111-654-30)

Billed under HCPCS

J7520 — Sirolimus, oral, 1 mg Medicare Part B payment limit (ASP + 6%): $0.74

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0904-7248 — Sirolimus, 16571-806 — Sirolimus, 16714-187 — sirolimus, 16714-188 — sirolimus, 16714-189 — sirolimus, 31722-316 — Sirolimus, 50268-718 — Sirolimus, 55111-653 — Sirolimus, 59762-1001 — SIROLIMUS, 59762-1002 — SIROLIMUS, 59762-1003 — SIROLIMUS, 59762-1205 — sirolimus, 60505-6197 — SIROLIMUS, 60687-902 — sirolimus, 65841-771 — sirolimus, 65841-772 — sirolimus, 65841-773 — sirolimus, 66689-347 — Sirolimus, 67877-746 — Sirolimus, 67877-747 — Sirolimus, +18 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.